Quadruple induction therapy including antithymocyte globulin or interleukin-2 receptor antibody or FK 506-based induction therapy after liver transplantation.

Source:http://linkedlifedata.com/resource/pubmed/id/10083151

Download in:

View as

General Info

PMID
10083151